Butterfly Network (BFLY) Gains from Investment Securities (2020 - 2026)
Butterfly Network (BFLY) reported Gains from Investment Securities of -$413000.0 for Q1 2026, up 50.0% on a YoY basis from -$275333.3 in Q1 2025, and down 99.52% sequentially from -$207000.0 in Q3 2025.
Butterfly Network (BFLY) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Gains from Investment Securities data on file, last reported at -$413000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 50.0% year-over-year to -$413000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 350.12% YoY), and the FY2024 full-year result was $1.9 million, up 141.31% from the prior year.
- Gains from Investment Securities eased to -$413000.0 in Q1 2026, from -$207000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $9.1 million in Q3 2022 to a low of -$12.8 million in Q2 2022.
- A 5-year average of -$1.6 million and a median of -$598000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities soared 279.34% in 2024 and tumbled 499.03% in 2025, its largest moves.
- Tracing BFLY's Gains from Investment Securities over 5 years: stood at -$12.0 million in 2022, then jumped by 95.19% to -$576000.0 in 2023, then soared by 279.34% to $1.0 million in 2024, then tumbled by 120.04% to -$207000.0 in 2025, then tumbled by 99.52% to -$413000.0 in 2026.
- Business Quant data shows BFLY's Gains from Investment Securities at -$413000.0 in Q1 2026, -$207000.0 in Q3 2025, and -$620000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -413,000.00 |
| Mar 31, 2026 | -413,000.00 |
| Sep 30, 2025 | -207,000.00 |
| Sep 30, 2025 | -207,000.00 |
| Jun 30, 2025 | -620,000.00 |
| Jun 30, 2025 | -620,000.00 |
| Mar 31, 2025 | -826,000.00 |
| Mar 31, 2025 | -826,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | -620,000.00 |
| Jun 30, 2024 | -620,000.00 |
| Mar 31, 2024 | 207,000.00 |
| Mar 31, 2024 | 207,000.00 |
| Dec 31, 2023 | -576,000.00 |
| Dec 31, 2023 | -576,000.00 |
| Sep 30, 2023 | -3.51 Mn |
| Sep 30, 2023 | -3.51 Mn |